Atlas Trials

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

Clinical trial NCT06512220 · RECRUITING

Trial details

NCT number
NCT06512220
Sponsor
Centre for Addiction and Mental Health
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Treatment Resistant Depression
Start date
2025-04-21
Primary completion
2027-04-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.